Idorsia Ltd (IDIA.SW)

CHF 1.3

(2.45%)

Eps Summary of Idorsia Ltd

  • Idorsia Ltd's latest annual eps in 2023 was -1.67 CHF , up 64.24% from previous year.
  • Idorsia Ltd's latest quarterly eps in 2024 Q3 was -0.55 CHF , up 11.67% from previous quarter.
  • Idorsia Ltd reported an annual eps of -4.67 CHF in 2022, down -23.87% from previous year.
  • Idorsia Ltd reported an annual eps of -3.77 CHF in 2021, down -20.83% from previous year.
  • Idorsia Ltd reported a quarterly eps of 0.17 CHF for 2024 Q1, up 126.15% from previous quarter.
  • Idorsia Ltd reported a quarterly eps of -0.60 CHF for 2024 Q2, down -452.94% from previous quarter.

Annual Eps Chart of Idorsia Ltd (2023 - 2016)

Historical Annual Eps of Idorsia Ltd (2023 - 2016)

Year Eps Eps Growth
2023 -1.67 CHF 64.24%
2022 -4.67 CHF -23.87%
2021 -3.77 CHF -20.83%
2020 -3.12 CHF 16.13%
2019 -3.72 CHF -21.57%
2018 -3.06 CHF -2450.0%
2017 -0.12 CHF 95.73%
2016 -2.81 CHF 0.0%

Peer Eps Comparison of Idorsia Ltd

Name Eps Eps Difference
Addex Therapeutics Ltd -0.14 CHF -1092.857%
BB Biotech AG -3.77 CHF 55.703%
Basilea Pharmaceutica AG 0.87 CHF 291.954%
Evolva Holding SA -19.50 CHF 91.436%
Kuros Biosciences AG -0.38 CHF -339.474%
Molecular Partners AG -1.89 CHF 11.64%
Relief Therapeutics Holding AG -8.35 CHF 80.0%
Santhera Pharmaceuticals Holding AG 5.18 CHF 132.239%